Global Pneumococcal Vaccine Polyvalent Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
According to our (Global Info Research) latest study, the global Pneumococcal Vaccine Polyvalent market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pneumococcal Vaccine Polyvalent industry chain, the market status of 18 Years and Younger (Prevnar 13, Pneumovax23), 19 To 64 Years Old (Prevnar 13, Pneumovax23), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pneumococcal Vaccine Polyvalent.
Regionally, the report analyzes the Pneumococcal Vaccine Polyvalent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pneumococcal Vaccine Polyvalent market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pneumococcal Vaccine Polyvalent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pneumococcal Vaccine Polyvalent industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Prevnar 13, Pneumovax23).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pneumococcal Vaccine Polyvalent market.
Regional Analysis: The report involves examining the Pneumococcal Vaccine Polyvalent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pneumococcal Vaccine Polyvalent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pneumococcal Vaccine Polyvalent:
Company Analysis: Report covers individual Pneumococcal Vaccine Polyvalent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pneumococcal Vaccine Polyvalent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (18 Years and Younger, 19 To 64 Years Old).
Technology Analysis: Report covers specific technologies relevant to Pneumococcal Vaccine Polyvalent. It assesses the current state, advancements, and potential future developments in Pneumococcal Vaccine Polyvalent areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pneumococcal Vaccine Polyvalent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pneumococcal Vaccine Polyvalent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Chapter 1, to describe Pneumococcal Vaccine Polyvalent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine Polyvalent, with price, sales, revenue and global market share of Pneumococcal Vaccine Polyvalent from 2019 to 2024.
Chapter 3, the Pneumococcal Vaccine Polyvalent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine Polyvalent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pneumococcal Vaccine Polyvalent market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccine Polyvalent.
Chapter 14 and 15, to describe Pneumococcal Vaccine Polyvalent sales channel, distributors, customers, research findings and conclusion.
Pneumococcal vaccines are vaccines against the bacteria Streptococcus pneumoniae. Their use can prevent some cases of pneumonia, meningitis, and sepsis.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Pneumococcal Vaccine Polyvalent industry chain, the market status of 18 Years and Younger (Prevnar 13, Pneumovax23), 19 To 64 Years Old (Prevnar 13, Pneumovax23), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Pneumococcal Vaccine Polyvalent.
Regionally, the report analyzes the Pneumococcal Vaccine Polyvalent markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Pneumococcal Vaccine Polyvalent market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Pneumococcal Vaccine Polyvalent market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Pneumococcal Vaccine Polyvalent industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Prevnar 13, Pneumovax23).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Pneumococcal Vaccine Polyvalent market.
Regional Analysis: The report involves examining the Pneumococcal Vaccine Polyvalent market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Pneumococcal Vaccine Polyvalent market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Pneumococcal Vaccine Polyvalent:
Company Analysis: Report covers individual Pneumococcal Vaccine Polyvalent manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Pneumococcal Vaccine Polyvalent This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (18 Years and Younger, 19 To 64 Years Old).
Technology Analysis: Report covers specific technologies relevant to Pneumococcal Vaccine Polyvalent. It assesses the current state, advancements, and potential future developments in Pneumococcal Vaccine Polyvalent areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Pneumococcal Vaccine Polyvalent market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Pneumococcal Vaccine Polyvalent market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
- Prevnar 13
- Pneumovax23
- 18 Years and Younger
- 19 To 64 Years Old
- 65 Years and Older
- Merck & Co.
- Pfizer
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Pneumococcal Vaccine Polyvalent product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Pneumococcal Vaccine Polyvalent, with price, sales, revenue and global market share of Pneumococcal Vaccine Polyvalent from 2019 to 2024.
Chapter 3, the Pneumococcal Vaccine Polyvalent competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Pneumococcal Vaccine Polyvalent breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Pneumococcal Vaccine Polyvalent market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Pneumococcal Vaccine Polyvalent.
Chapter 14 and 15, to describe Pneumococcal Vaccine Polyvalent sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Pneumococcal Vaccine Polyvalent
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Pneumococcal Vaccine Polyvalent Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Prevnar
1.3.3 Pneumovax23
1.4 Market Analysis by Application
1.4.1 Overview: Global Pneumococcal Vaccine Polyvalent Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 18 Years and Younger
1.4.3 19 To 64 Years Old
1.4.4 65 Years and Older
1.5 Global Pneumococcal Vaccine Polyvalent Market Size & Forecast
1.5.1 Global Pneumococcal Vaccine Polyvalent Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Pneumococcal Vaccine Polyvalent Sales Quantity (2019-2030)
1.5.3 Global Pneumococcal Vaccine Polyvalent Average Price (2019-2030)
2 MANUFACTURERS PROFILES
2.1 Merck & Co.
2.1.1 Merck & Co. Details
2.1.2 Merck & Co. Major Business
2.1.3 Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
2.1.4 Merck & Co. Pneumococcal Vaccine Polyvalent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Merck & Co. Recent Developments/Updates
2.2 Pfizer
2.2.1 Pfizer Details
2.2.2 Pfizer Major Business
2.2.3 Pfizer Pneumococcal Vaccine Polyvalent Product and Services
2.2.4 Pfizer Pneumococcal Vaccine Polyvalent Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Pfizer Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: PNEUMOCOCCAL VACCINE POLYVALENT BY MANUFACTURER
3.1 Global Pneumococcal Vaccine Polyvalent Sales Quantity by Manufacturer (2019-2024)
3.2 Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019-2024)
3.3 Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Pneumococcal Vaccine Polyvalent by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2023
3.4.2 Top 6 Pneumococcal Vaccine Polyvalent Manufacturer Market Share in 2023
3.5 Pneumococcal Vaccine Polyvalent Market: Overall Company Footprint Analysis
3.5.1 Pneumococcal Vaccine Polyvalent Market: Region Footprint
3.5.2 Pneumococcal Vaccine Polyvalent Market: Company Product Type Footprint
3.5.3 Pneumococcal Vaccine Polyvalent Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Pneumococcal Vaccine Polyvalent Market Size by Region
4.1.1 Global Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2030)
4.1.2 Global Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2030)
4.1.3 Global Pneumococcal Vaccine Polyvalent Average Price by Region (2019-2030)
4.2 North America Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030)
4.3 Europe Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030)
4.4 Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030)
4.5 South America Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030)
4.6 Middle East and Africa Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030)
5 MARKET SEGMENT BY TYPE
5.1 Global Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2030)
5.2 Global Pneumococcal Vaccine Polyvalent Consumption Value by Type (2019-2030)
5.3 Global Pneumococcal Vaccine Polyvalent Average Price by Type (2019-2030)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2030)
6.2 Global Pneumococcal Vaccine Polyvalent Consumption Value by Application (2019-2030)
6.3 Global Pneumococcal Vaccine Polyvalent Average Price by Application (2019-2030)
7 NORTH AMERICA
7.1 North America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2030)
7.2 North America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2030)
7.3 North America Pneumococcal Vaccine Polyvalent Market Size by Country
7.3.1 North America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2030)
7.3.2 North America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8 EUROPE
8.1 Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2030)
8.2 Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2030)
8.3 Europe Pneumococcal Vaccine Polyvalent Market Size by Country
8.3.1 Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2030)
8.3.2 Europe Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9 ASIA-PACIFIC
9.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Pneumococcal Vaccine Polyvalent Market Size by Region
9.3.1 Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10 SOUTH AMERICA
10.1 South America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2030)
10.2 South America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2030)
10.3 South America Pneumococcal Vaccine Polyvalent Market Size by Country
10.3.1 South America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2030)
10.3.2 South America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Pneumococcal Vaccine Polyvalent Market Size by Country
11.3.1 Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12 MARKET DYNAMICS
12.1 Pneumococcal Vaccine Polyvalent Market Drivers
12.2 Pneumococcal Vaccine Polyvalent Market Restraints
12.3 Pneumococcal Vaccine Polyvalent Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Pneumococcal Vaccine Polyvalent and Key Manufacturers
13.2 Manufacturing Costs Percentage of Pneumococcal Vaccine Polyvalent
13.3 Pneumococcal Vaccine Polyvalent Production Process
13.4 Pneumococcal Vaccine Polyvalent Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Pneumococcal Vaccine Polyvalent Typical Distributors
14.3 Pneumococcal Vaccine Polyvalent Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
Table 6. Merck & Co. Pneumococcal Vaccine Polyvalent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck & Co. Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Pneumococcal Vaccine Polyvalent Product and Services
Table 11. Pfizer Pneumococcal Vaccine Polyvalent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 14. Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019-2024) & (USD Million)
Table 15. Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 16. Market Position of Manufacturers in Pneumococcal Vaccine Polyvalent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 17. Head Office and Pneumococcal Vaccine Polyvalent Production Site of Key Manufacturer
Table 18. Pneumococcal Vaccine Polyvalent Market: Company Product Type Footprint
Table 19. Pneumococcal Vaccine Polyvalent Market: Company Product Application Footprint
Table 20. Pneumococcal Vaccine Polyvalent New Market Entrants and Barriers to Market Entry
Table 21. Pneumococcal Vaccine Polyvalent Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2024) & (K Units)
Table 23. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2025-2030) & (K Units)
Table 24. Global Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2024) & (USD Million)
Table 25. Global Pneumococcal Vaccine Polyvalent Consumption Value by Region (2025-2030) & (USD Million)
Table 26. Global Pneumococcal Vaccine Polyvalent Average Price by Region (2019-2024) & (USD/Unit)
Table 27. Global Pneumococcal Vaccine Polyvalent Average Price by Region (2025-2030) & (USD/Unit)
Table 28. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 29. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 30. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type (2019-2024) & (USD Million)
Table 31. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type (2025-2030) & (USD Million)
Table 32. Global Pneumococcal Vaccine Polyvalent Average Price by Type (2019-2024) & (USD/Unit)
Table 33. Global Pneumococcal Vaccine Polyvalent Average Price by Type (2025-2030) & (USD/Unit)
Table 34. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 35. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 36. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application (2019-2024) & (USD Million)
Table 37. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application (2025-2030) & (USD Million)
Table 38. Global Pneumococcal Vaccine Polyvalent Average Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Pneumococcal Vaccine Polyvalent Average Price by Application (2025-2030) & (USD/Unit)
Table 40. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 41. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 42. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 43. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 44. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2024) & (K Units)
Table 45. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2025-2030) & (K Units)
Table 46. North America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2024) & (USD Million)
Table 47. North America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2025-2030) & (USD Million)
Table 48. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 51. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 52. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2024) & (K Units)
Table 53. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2025-2030) & (K Units)
Table 54. Europe Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Pneumococcal Vaccine Polyvalent Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 57. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 58. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 59. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 60. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2024) & (K Units)
Table 61. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2025-2030) & (K Units)
Table 62. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2024) & (USD Million)
Table 63. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value by Region (2025-2030) & (USD Million)
Table 64. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 65. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 66. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 67. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 68. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2024) & (K Units)
Table 69. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2025-2030) & (K Units)
Table 70. South America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2024) & (USD Million)
Table 71. South America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 73. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 74. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2024) & (K Units)
Table 77. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2025-2030) & (K Units)
Table 78. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value by Region (2025-2030) & (USD Million)
Table 80. Pneumococcal Vaccine Polyvalent Raw Material
Table 81. Key Manufacturers of Pneumococcal Vaccine Polyvalent Raw Materials
Table 82. Pneumococcal Vaccine Polyvalent Typical Distributors
Table 83. Pneumococcal Vaccine Polyvalent Typical Customers
Table 1. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 4. Merck & Co. Major Business
Table 5. Merck & Co. Pneumococcal Vaccine Polyvalent Product and Services
Table 6. Merck & Co. Pneumococcal Vaccine Polyvalent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Merck & Co. Recent Developments/Updates
Table 8. Pfizer Basic Information, Manufacturing Base and Competitors
Table 9. Pfizer Major Business
Table 10. Pfizer Pneumococcal Vaccine Polyvalent Product and Services
Table 11. Pfizer Pneumococcal Vaccine Polyvalent Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. Pfizer Recent Developments/Updates
Table 13. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 14. Global Pneumococcal Vaccine Polyvalent Revenue by Manufacturer (2019-2024) & (USD Million)
Table 15. Global Pneumococcal Vaccine Polyvalent Average Price by Manufacturer (2019-2024) & (USD/Unit)
Table 16. Market Position of Manufacturers in Pneumococcal Vaccine Polyvalent, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 17. Head Office and Pneumococcal Vaccine Polyvalent Production Site of Key Manufacturer
Table 18. Pneumococcal Vaccine Polyvalent Market: Company Product Type Footprint
Table 19. Pneumococcal Vaccine Polyvalent Market: Company Product Application Footprint
Table 20. Pneumococcal Vaccine Polyvalent New Market Entrants and Barriers to Market Entry
Table 21. Pneumococcal Vaccine Polyvalent Mergers, Acquisition, Agreements, and Collaborations
Table 22. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2024) & (K Units)
Table 23. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2025-2030) & (K Units)
Table 24. Global Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2024) & (USD Million)
Table 25. Global Pneumococcal Vaccine Polyvalent Consumption Value by Region (2025-2030) & (USD Million)
Table 26. Global Pneumococcal Vaccine Polyvalent Average Price by Region (2019-2024) & (USD/Unit)
Table 27. Global Pneumococcal Vaccine Polyvalent Average Price by Region (2025-2030) & (USD/Unit)
Table 28. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 29. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 30. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type (2019-2024) & (USD Million)
Table 31. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type (2025-2030) & (USD Million)
Table 32. Global Pneumococcal Vaccine Polyvalent Average Price by Type (2019-2024) & (USD/Unit)
Table 33. Global Pneumococcal Vaccine Polyvalent Average Price by Type (2025-2030) & (USD/Unit)
Table 34. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 35. Global Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 36. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application (2019-2024) & (USD Million)
Table 37. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application (2025-2030) & (USD Million)
Table 38. Global Pneumococcal Vaccine Polyvalent Average Price by Application (2019-2024) & (USD/Unit)
Table 39. Global Pneumococcal Vaccine Polyvalent Average Price by Application (2025-2030) & (USD/Unit)
Table 40. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 41. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 42. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 43. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 44. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2024) & (K Units)
Table 45. North America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2025-2030) & (K Units)
Table 46. North America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2024) & (USD Million)
Table 47. North America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2025-2030) & (USD Million)
Table 48. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 49. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 50. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 51. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 52. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2024) & (K Units)
Table 53. Europe Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2025-2030) & (K Units)
Table 54. Europe Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2024) & (USD Million)
Table 55. Europe Pneumococcal Vaccine Polyvalent Consumption Value by Country (2025-2030) & (USD Million)
Table 56. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 57. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 58. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 59. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 60. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2024) & (K Units)
Table 61. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2025-2030) & (K Units)
Table 62. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2024) & (USD Million)
Table 63. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value by Region (2025-2030) & (USD Million)
Table 64. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 65. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 66. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 67. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 68. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2019-2024) & (K Units)
Table 69. South America Pneumococcal Vaccine Polyvalent Sales Quantity by Country (2025-2030) & (K Units)
Table 70. South America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2019-2024) & (USD Million)
Table 71. South America Pneumococcal Vaccine Polyvalent Consumption Value by Country (2025-2030) & (USD Million)
Table 72. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2019-2024) & (K Units)
Table 73. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Type (2025-2030) & (K Units)
Table 74. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2019-2024) & (K Units)
Table 75. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Application (2025-2030) & (K Units)
Table 76. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2019-2024) & (K Units)
Table 77. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity by Region (2025-2030) & (K Units)
Table 78. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value by Region (2019-2024) & (USD Million)
Table 79. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value by Region (2025-2030) & (USD Million)
Table 80. Pneumococcal Vaccine Polyvalent Raw Material
Table 81. Key Manufacturers of Pneumococcal Vaccine Polyvalent Raw Materials
Table 82. Pneumococcal Vaccine Polyvalent Typical Distributors
Table 83. Pneumococcal Vaccine Polyvalent Typical Customers
LIST OF FIGURES
Figure 1. Pneumococcal Vaccine Polyvalent Picture
Figure 2. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Type in 2023
Figure 4. Prevnar 13 Examples
Figure 5. Pneumovax23 Examples
Figure 6. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Application in 2023
Figure 8. 18 Years and Younger Examples
Figure 9. 19 To 64 Years Old Examples
Figure 10. 65 Years and Older Examples
Figure 11. Global Pneumococcal Vaccine Polyvalent Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Pneumococcal Vaccine Polyvalent Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Pneumococcal Vaccine Polyvalent Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Pneumococcal Vaccine Polyvalent Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Pneumococcal Vaccine Polyvalent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Pneumococcal Vaccine Polyvalent Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Pneumococcal Vaccine Polyvalent Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Pneumococcal Vaccine Polyvalent Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Pneumococcal Vaccine Polyvalent Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Region (2019-2030)
Figure 53. China Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Pneumococcal Vaccine Polyvalent Market Drivers
Figure 74. Pneumococcal Vaccine Polyvalent Market Restraints
Figure 75. Pneumococcal Vaccine Polyvalent Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine Polyvalent in 2023
Figure 78. Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent
Figure 79. Pneumococcal Vaccine Polyvalent Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
Figure 1. Pneumococcal Vaccine Polyvalent Picture
Figure 2. Global Pneumococcal Vaccine Polyvalent Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Type in 2023
Figure 4. Prevnar 13 Examples
Figure 5. Pneumovax23 Examples
Figure 6. Global Pneumococcal Vaccine Polyvalent Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 7. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Application in 2023
Figure 8. 18 Years and Younger Examples
Figure 9. 19 To 64 Years Old Examples
Figure 10. 65 Years and Older Examples
Figure 11. Global Pneumococcal Vaccine Polyvalent Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 12. Global Pneumococcal Vaccine Polyvalent Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 13. Global Pneumococcal Vaccine Polyvalent Sales Quantity (2019-2030) & (K Units)
Figure 14. Global Pneumococcal Vaccine Polyvalent Average Price (2019-2030) & (USD/Unit)
Figure 15. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Manufacturer in 2023
Figure 16. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Manufacturer in 2023
Figure 17. Producer Shipments of Pneumococcal Vaccine Polyvalent by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 18. Top 3 Pneumococcal Vaccine Polyvalent Manufacturer (Consumption Value) Market Share in 2023
Figure 19. Top 6 Pneumococcal Vaccine Polyvalent Manufacturer (Consumption Value) Market Share in 2023
Figure 20. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Region (2019-2030)
Figure 21. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Region (2019-2030)
Figure 22. North America Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 28. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Type (2019-2030)
Figure 29. Global Pneumococcal Vaccine Polyvalent Average Price by Type (2019-2030) & (USD/Unit)
Figure 30. Global Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 31. Global Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Application (2019-2030)
Figure 32. Global Pneumococcal Vaccine Polyvalent Average Price by Application (2019-2030) & (USD/Unit)
Figure 33. North America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 34. North America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 35. North America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Country (2019-2030)
Figure 36. North America Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Country (2019-2030)
Figure 37. United States Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 38. Canada Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 39. Mexico Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 40. Europe Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 41. Europe Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 42. Europe Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Country (2019-2030)
Figure 43. Europe Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 45. France Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 46. United Kingdom Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 47. Russia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 48. Italy Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Region (2019-2030)
Figure 52. Asia-Pacific Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Region (2019-2030)
Figure 53. China Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 54. Japan Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 55. Korea Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 56. India Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 57. Southeast Asia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Australia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. South America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 60. South America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 61. South America Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Country (2019-2030)
Figure 62. South America Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Country (2019-2030)
Figure 63. Brazil Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 64. Argentina Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 65. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Type (2019-2030)
Figure 66. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Application (2019-2030)
Figure 67. Middle East & Africa Pneumococcal Vaccine Polyvalent Sales Quantity Market Share by Region (2019-2030)
Figure 68. Middle East & Africa Pneumococcal Vaccine Polyvalent Consumption Value Market Share by Region (2019-2030)
Figure 69. Turkey Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 70. Egypt Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 71. Saudi Arabia Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 72. South Africa Pneumococcal Vaccine Polyvalent Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 73. Pneumococcal Vaccine Polyvalent Market Drivers
Figure 74. Pneumococcal Vaccine Polyvalent Market Restraints
Figure 75. Pneumococcal Vaccine Polyvalent Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Pneumococcal Vaccine Polyvalent in 2023
Figure 78. Manufacturing Process Analysis of Pneumococcal Vaccine Polyvalent
Figure 79. Pneumococcal Vaccine Polyvalent Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source
